CN1826097A - 含地西泮的经鼻微乳 - Google Patents
含地西泮的经鼻微乳 Download PDFInfo
- Publication number
- CN1826097A CN1826097A CNA2004800213163A CN200480021316A CN1826097A CN 1826097 A CN1826097 A CN 1826097A CN A2004800213163 A CNA2004800213163 A CN A2004800213163A CN 200480021316 A CN200480021316 A CN 200480021316A CN 1826097 A CN1826097 A CN 1826097A
- Authority
- CN
- China
- Prior art keywords
- microemulsion
- diazepam
- alcohol
- polyoxyethylene sorbitan
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
组分 | 配方A(%w/w) | 配方B(%w/w) | 配方C(%w/w) |
月桂酸乙酯 | 15.0 | 15.0 | 15.0 |
聚山梨酯80 | 23.3 | 23.3 | 20.0 |
丙二醇 | 20.0 | 16.7 | 20.0 |
乙醇 | 26.7 | 30.0 | 30.0 |
水 | 15.0 | 15.0 | 15.0 |
Claims (16)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47928103P | 2003-06-17 | 2003-06-17 | |
US60/479,281 | 2003-06-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1826097A true CN1826097A (zh) | 2006-08-30 |
CN100421649C CN100421649C (zh) | 2008-10-01 |
Family
ID=33551875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004800213163A Expired - Fee Related CN100421649C (zh) | 2003-06-17 | 2004-06-15 | 含地西泮的经鼻微乳 |
Country Status (12)
Country | Link |
---|---|
US (1) | US20050002987A1 (zh) |
EP (1) | EP1633326A4 (zh) |
JP (1) | JP2006527764A (zh) |
KR (1) | KR20060012030A (zh) |
CN (1) | CN100421649C (zh) |
AU (1) | AU2004246961B2 (zh) |
BR (1) | BRPI0411572A (zh) |
CA (1) | CA2529489C (zh) |
MX (1) | MXPA05014060A (zh) |
RU (1) | RU2354354C2 (zh) |
TW (1) | TWI349552B (zh) |
WO (1) | WO2004110403A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101534804B (zh) * | 2006-11-15 | 2013-05-08 | 爱思开生物制药株式会社 | 经鼻抗惊厥药物组合物 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070021411A1 (en) * | 2005-05-11 | 2007-01-25 | Cloyd James C | Supersaturated benzodiazepine solutions and their delivery |
TW200824693A (en) | 2006-08-28 | 2008-06-16 | Jazz Pharmaceuticals Inc | Pharmaceutical compositions of clonazepam and methods of use thereof |
WO2009046444A2 (en) * | 2007-10-05 | 2009-04-09 | Mdrna, Inc. | Formulation for intranasal administration of diazepam |
KR101517415B1 (ko) * | 2008-05-14 | 2015-05-07 | 에스케이바이오팜 주식회사 | 난용성 항경련제를 함유하는 경비 항경련성 약학 조성물 |
US20160000803A1 (en) * | 2013-02-22 | 2016-01-07 | Eastgate Pharmaceuticals Inc. | Pharmaceutical composition for transmucosal administration of benzodiazepines |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4950664A (en) * | 1988-09-16 | 1990-08-21 | Rugby-Darby Group Companies, Inc. | Nasal administration of benzodiazepine hypnotics |
US4994439A (en) * | 1989-01-19 | 1991-02-19 | California Biotechnology Inc. | Transmembrane formulations for drug administration |
DE69129110T2 (de) * | 1990-05-10 | 1998-12-10 | Bechgaard International Research And Development A/S, Hellerup | Pharmazeutische zubereitung enthaltend n-glykofurole und n-äthylenglykole |
US6267985B1 (en) * | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
KR100715513B1 (ko) * | 1999-07-26 | 2007-05-08 | 에스케이 코오포레이션 | 경비 항경련성 조성물 |
-
2004
- 2004-06-15 CA CA2529489A patent/CA2529489C/en not_active Expired - Fee Related
- 2004-06-15 TW TW093117138A patent/TWI349552B/zh not_active IP Right Cessation
- 2004-06-15 JP JP2006516926A patent/JP2006527764A/ja active Pending
- 2004-06-15 CN CNB2004800213163A patent/CN100421649C/zh not_active Expired - Fee Related
- 2004-06-15 RU RU2006100112/15A patent/RU2354354C2/ru not_active IP Right Cessation
- 2004-06-15 AU AU2004246961A patent/AU2004246961B2/en not_active Ceased
- 2004-06-15 KR KR1020057024109A patent/KR20060012030A/ko active IP Right Grant
- 2004-06-15 WO PCT/KR2004/001424 patent/WO2004110403A1/en active Application Filing
- 2004-06-15 BR BRPI0411572-4A patent/BRPI0411572A/pt not_active IP Right Cessation
- 2004-06-15 EP EP04773929A patent/EP1633326A4/en not_active Withdrawn
- 2004-06-15 MX MXPA05014060A patent/MXPA05014060A/es active IP Right Grant
- 2004-06-16 US US10/869,195 patent/US20050002987A1/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101534804B (zh) * | 2006-11-15 | 2013-05-08 | 爱思开生物制药株式会社 | 经鼻抗惊厥药物组合物 |
Also Published As
Publication number | Publication date |
---|---|
RU2006100112A (ru) | 2006-06-27 |
EP1633326A4 (en) | 2012-01-18 |
CA2529489C (en) | 2012-01-03 |
CA2529489A1 (en) | 2004-12-23 |
AU2004246961B2 (en) | 2010-04-22 |
BRPI0411572A (pt) | 2006-08-08 |
AU2004246961A1 (en) | 2004-12-23 |
EP1633326A1 (en) | 2006-03-15 |
TWI349552B (en) | 2011-10-01 |
TW200509943A (en) | 2005-03-16 |
WO2004110403A1 (en) | 2004-12-23 |
US20050002987A1 (en) | 2005-01-06 |
KR20060012030A (ko) | 2006-02-06 |
MXPA05014060A (es) | 2006-03-17 |
CN100421649C (zh) | 2008-10-01 |
RU2354354C2 (ru) | 2009-05-10 |
JP2006527764A (ja) | 2006-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1073470B1 (en) | Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients | |
TWI269652B (en) | Transnasal anticonvulsive compositions and modulated process | |
US6849263B2 (en) | Pharmaceutical compositions for buccal delivery of pain relief medications | |
ES2199868T3 (es) | Nueva combinacion de loteprednol y productos antihistaminicos. | |
KR101517415B1 (ko) | 난용성 항경련제를 함유하는 경비 항경련성 약학 조성물 | |
JP6112867B2 (ja) | サキシトキシン誘導体での触覚の喪失の処置 | |
JPH01501709A (ja) | カフェインの経鼻投与 | |
US7112561B2 (en) | Pharmaceutical compositions and methods for insulin treatment | |
US20040258623A1 (en) | Insulin-containing oral spray and the preparation method thereof | |
CN100421649C (zh) | 含地西泮的经鼻微乳 | |
US8889663B2 (en) | Formulation for oral transmucosal administration of lipid-lowering drugs | |
JP2015511934A (ja) | スタチンの舌下投与 | |
EP2086524B1 (en) | Transnasal anticonvulsive pharmaceutical composition | |
JPS60115516A (ja) | 自律神経系用薬剤 | |
GB2162745A (en) | Nasal compositions | |
CN106361700A (zh) | 盐酸纳美芬鼻腔给药制剂 | |
JPS6272617A (ja) | 鼻腔内投与用薬剤組成物 | |
US12053479B2 (en) | Transdermal treatment for erectile dysfunction | |
JP3597233B2 (ja) | 経鼻組成物及びそれを含有する経鼻製剤 | |
WO2004082670A1 (en) | Methadone-containing compositions for parenteral administration and use thereof | |
JPH06247869A (ja) | 経気道吸収剤及び経鼻吸収剤 | |
AU2003263416C1 (en) | Pharmaceutical compositions for buccal delivery of pain relief medications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SK BIOPHARMACEUTICALS CO., LTD. Free format text: FORMER OWNER: SK LTD. Effective date: 20120229 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20120229 Address after: Seoul, South Kerean Patentee after: SK Biopharmaceuticals Co., Ltd. Address before: Seoul, South Kerean Patentee before: SK Ltd. |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20081001 Termination date: 20130615 |